Effect of an out-of-pocket insulin cap in Medicare part D
{{output}}
Introduction: Out-of-pocket (OOP) costs can often impede patients' access to prescription drugs. The Inflation Reduction Act of 2022 (IRA) limited OOP costs for insulin products covered by the Medicare Part B and Part D programs... ...
